Jonathan A. Carnella - Jun 21, 2023 Form 4 Insider Report for NorthStar Healthcare Income, Inc. (NONE)

Role
Director
Signature
/s/ Nicholas R. Balzo, as Attorney-in-Fact
Stock symbol
NONE
Transactions as of
Jun 21, 2023
Transactions value $
$0
Form type
4
Date filed
6/22/2023, 04:50 PM
Previous filing
Jul 1, 2022
Next filing
Jun 24, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NONE Common Stock Award +29K 29K Jun 21, 2023 Direct F1, F2, F3
transaction NONE Common Stock Gift $0 -29K -100% $0.00* 0 Jun 21, 2023 Direct
transaction NONE Common Stock Gift $0 +29K +57.97% $0.00 79.1K Jun 21, 2023 See Footnote F4
holding NONE Common Stock 50K Jun 21, 2023 See Footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to the NorthStar Healthcare Income, Inc. (the "Company") Fifth Amended and Restated Independent Directors Compensation Plan (the "Plan"), each of the Company's independent directors receives a grant of $85,000 in restricted stock units ("Restricted Stock Units") convertible, on a one-for-one-basis, into common stock, par value $0.01, of the Company (the "Common Stock") following re-election to the Company's Board of Directors.
F2 The Restricted Stock Units vest quarterly over a two year period with an initial vesting date of July 1, 2023. Unless forfeited prior to the applicable vesting date, the Restricted Stock Units will be converted into shares of Common Stock on the earlier of (i) Change in Control (as defined in Section 409A of the Code) or (ii) the date of the director's "separation from service" (as defined in Section 409A of the Code).
F3 Pursuant to the Plan, the amount of Restricted Stock Units was determined by dividing the fixed grant value of $85,000 by the most recently disclosed net asset value of the Company's common stock, or $2.93.
F4 By family revocable trust.

Remarks:

See Exhibit 24 Power of Attorney